Updates on therapeutic development, commercial strategy, drug launches, manufacturing, safety insights, and lifecycle management across the pharmaceutical industry.
Korean biotech successfully launches on Korea Exchange with focus on once-monthly injectable treatments including Alzheimer’s candidate G2Gbio completed its public market debut on the Korea
Revolutionary needle-free epinephrine achieves $15.7M quarterly revenue with accelerating market adoption ARS Pharmaceuticals delivered exceptional Q2 2025 results with $15.7 million in total revenue, including
Senior credit facility supports Afrezza pediatric launch, commercial expansion, and pipeline advancement MannKind Corporation secured up to $500 million in a senior credit facility from
Inflammatory disease biotech pursues unprecedented combination of drug development and Ethereum treasury management In an unusual move for biotechnology, 180 Life Sciences announced a massive
Inflammatory disease biotech pursues unprecedented combination of drug development and Ethereum treasury management In an unusual move for biotechnology, 180 Life Sciences announced a massive
Quick Summary Drug Development: Novo Nordisk plans to expand its obesity drug’s applications to treat metabolic-associated steatohepatitis (MASH). Clinical Findings: New trials indicate the drug’s
Quick Summary Issue: Asian pharmaceutical suppliers are producing and exporting cheaper versions of semaglutide, the active ingredient in Ozempic and Wegovy. Key Players: Incepta Pharmaceuticals
Quick Summary Investment: Sanofi has invested $300 million for a 16% stake in OranoMed. Partnership Focus: Developing radiopharmaceuticals for targeted cancer treatment. Impact: Expands Sanofi’s
Pfizer’s Respiratory Syncytial Virus (RSV) vaccine, Abrysvo, recently received FDA approval for use in adults aged 18 to 59 who are at increased risk for
In a significant breakthrough, the FDA has approved two new drugs for the treatment of Niemann-Pick Disease Type C (NPC), a rare and debilitating genetic
